PharmaResearch financials at a glance

+ Portfolio

The revenue of PharmaResearch is reported as 260.83717 billion Won in the fiscal year 2023. The earnings were 8092.33 Won per share in 2023, which was 12.99 lower than 2021. And about 111.6 billion Won are reported as free cash flow in the financials of PharmaResearch 2023. Dividends of 745 Won per share were paid to shareholders of PharmaResearch stock KOSDAQ:A214450 in fiscal 2023.

₩197.17B

Revenue

₩4.11k

Earnings Per Share

72.66%

Gross Margin %

₩42.19B

Free Cash Flow

Revenue

197,167.75

Earnings Per Share

4,114.00

Gross Margin %

72.66

Free Cash Flow

42,190.35

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2016	2015	2014
Rev.	Revenue	N/A	₩197.17B	₩154.08B	₩108.75B	₩83.87B	₩64.28B	₩45.95B	₩37.44B	₩0.00M
GM %	Gross Margin %	73.88%	72.66%	70.31%	67.03%	59.74%	59.45%	67.11%	68.80%	0.00%
OM	Operating Margin	36.23%	33.85%	34.07%	30.74%	22.73%	13.54%	30.69%	42.97%	0.00%
EPS	Earnings Per Share	₩6.42k	₩4.11k	₩4.73k	₩3.45k	₩1.85k	₩1.52k	₩1.47k	₩1.25k	₩930.00
Div.	Dividends	N/A	₩660.00	₩600.00	₩500.00	₩300.00	₩0.00	₩300.00	₩210.00	₩0.00
PR %	Payout Ratio %	0	16.04%	12.69%	14.51%	16.26%	0.00%	20.39%	16.77%	0
Sha.	Shares	N/AM	9.98M	9.98M	9.65M	9.42M	9.46M	9.4M	9.16M	0M
OCF	Operating Cash Flow	N/A	₩59.40B	₩65.30B	₩32.39B	₩19.43B	₩5.20B	₩8.24B	₩16.02B	₩0.00M
FCF	Free Cash Flow	N/A	₩42.19B	₩44.65B	₩-2,393.31M	₩9.84B	₩-23,394.22M	₩6.86B	₩15.67B	₩0.00M
FCFS	Free Cash Flow Per Share	₩4.16k	₩4.18k	₩4.23k	₩-,314.65	₩1.01k	₩-2,058.52	₩673.96	₩2.04k	₩0.00

PharmaResearch financials at a glance

Financials

Discover